“The pharmaceutical sector has always been a catalyst for human progress. Now, we are equally committed to advancing a biopositive future where innovation and responsibility move hand in hand,” shares Dr. Rajesh Jain, Chairman, CII National Committee on Biotechnology & MD, @PanaceaBiotec, as he invites the industry to the 7th CII Pharma & Lifesciences Summit. @DrRajeshPanacea #CIIPharmaAndLifesciencesSummit #CII4Pharma #CII4Lifesciences @CII4Health

The 7th CII Pharma & Lifesciences Summit will convene leaders, policymakers and innovators to explore theme of “Progress, Promise and the Planet: Unlocking Sustainable Growth in Indian Pharma & Life Sciences.” Join us on 12 December 2025 in New Delhi for insights on sustainable practices, talent, technology, ethical trials and good governance. #CIIPharmaAndLifesciencesSummit #CII4Pharma #CII4Lifesciences @CII4Health @DrJitendraSingh @PanaceaBiotec @drreddys @AbbottNews @BioconBiologics @SunPharma_Live @Bayer @BSV_Global @LupinGlobal @Pharma_Mankind @DeloitteIndia @vohglobal

Today’s topic ‘Progress, Promise and Planet - Unlocking Sustainable Growth in Indian Pharma and Life Sciences’ is basically saying that with access and affordability, which were always the theme, we are now talking about accountability, towards the world, the planet, the people, the human world and that accountability should drive us further as we think about better healthcare and growth, and that is the big change that we are talking about today. -Sanjiv Navangul, Managing Director & Chief Executive Officer, Bharat Serums & Vaccines Limited (A Mankind Group Company) at the 7th #CIIPharmaAndLifesciencesSummit #CII4Pharma #CII4Lifesciences @CII4Health

We must ensure as a collective leadership that the industry leads and remains committed to leading through innovation, sustainability and digital transformation. We firmly believe that the Government must continue to enable bold experimentation, regulators must remain partners in progress, academia must keep driving the discoveries of tomorrow and global partners must collaborate with India as co-creators, not merely as consumers. The next two decades will shape India into a true life sciences powerhouse driven by our science, our scale, our sustainability efforts, our digital transformation and our human commitment. - Dr Rajesh Jain, Chairman, CII National Committee on Biotechnology & Chairman & Managing Director, @PanaceaBiotec, at the 7th #CIIPharmaAndLifesciencesSummit #CII4Pharma #CII4Lifesciences @DrRajeshPanacea @CII4Health

A key transformation for the pharma industry is that while we were once primarily retailers, we are now creating innovations of our own. A recent example made possible with the active support of the Government of India is the development of Naphithromycin, the first-ever indigenous antibiotic, highly effective in treating resistant respiratory infections. Today we are exporting preventive healthcare. It is a complete 360 transformation, considering India was not taken seriously as healthcare provider. - Dr Jitendra Singh, Minister Of State (Independent Charge) of The Ministry of Science and Technology; Minister of State (Independent Charge) of The Ministry of Earth Sciences; Minister of State in the Prime Minister’s Office; Minister Of State in the Ministry of Personnel, Public Grievances and Pensions; Minister of State in the Department of Atomic Energy and Minister of State in the Department of Space, at the 7th #CIIPharmaAndLifesciencesSummit @DrJitendraSingh #CII4Pharma #CII4Lifesciences

We must find value addition, and that comes from innovation. We should focus on innovation and increase our spending on R&D to become a global power in pharma by 2047. What we require is a very strong regulatory system that builds trust in the minds of patients not only in India but across the globe. Ultimately, we must come together to find solutions and develop a regulatory framework unique to our country, grounded in the principles of global convergence, so that we can continue providing quality products at affordable prices and produce innovative products. -Dr Chandrashekhar Ranga, Joint Drugs Controller General of India (JDCGI) Central Drugs Standard Control Organization (CDSCO), at the 7th #CIIPharmaAndLifesciencesSummit @CDSCO_INDIA_INF #CII4Pharma #CII4Lifesciences

Sustainability is a composite of environmental responsibility and health equity, which is a resilience strategy. Companies, to be better positioned and remain globally competitive, must invest early in climate-smart operations, renewable energy, greener processes, and responsible supply chains. Equitable access in pharma is equally important for defining long-term sustainability. There are three ways in which access becomes a sustainability accelerator: partnerships with government to address public health issues, industry and peer-led partnerships to expand access to healthcare, and affordability mechanisms for patients for access to drugs at a larger level. Companies that excel in both will define the future of India and global pharma.-Shweta Rai, Managing Director-India and Country Division Head of South Asia Bayer Pharmaceutical, at the 7th #CIIPharmaAndLifesciencesSummit #CII4Pharma #CII4Lifesciences

The CII Pharma & Life Sciences Summit 2025 is set to bring together senior industry leaders, policymakers, researchers, and innovators to deliberate on how Indian pharma and Life sciences can grow sustainably while staying globally competitive, while exploring the theme 'Progress, Promise and the Planet: Unlocking Sustainable Growth in Indian Pharma & Life Sciences.' Join in for diverse perspectives on sustainable business practices, talent development, tech-driven pharma sustainability, ethical clinical trials, environmental regulations, and good governance on 12 December 2025 in New Delhi. Registration Link: lnkd.in/d6P7Bzm6 @CII4Health #CIIPharmaAndLifesciencesSummit

Whenever health solutions are being made, we make sure that accessibility and inclusivity is there, be it a digital solution or a medical device, as long as we make sure that it is accessible, the whole concept of coverage and making sure that no one is left out is achieved. - Kiran Gopal Vaska, Joint Secretary, National Health Authority (NHA) and Mission Director, Ayushman Bharat Digital Mission (ABDM) at the 4th #CIIDigitalHealthSummit25 #CII4DigitalHealth #CII4Health #AIinHealth #HealthcareInnovation #PoweringDigitalHealth @CII4Health @AyushmanNHA

Vijayendra Singh, Chief Operating Officer, Apollo 24|7, moderating the session 'Evolution of the Policy and Regulatory Frameworks that Govern Digital Health Sectoral Growth and Expansion' at the 4th #CIIDigitalHealthSummit25. #CII4DigitalHealth #CII4Health #AIinHealth #HealthcareInnovation #PoweringDigitalHealth @CII4Health @Apollo24x7

When we talk about technology in healthcare, we should look at how it can improve availability of healthcare & medicine, its accessibility, quality and affordability. - Madhukar Kumar Bhagat, Joint Secretary, Ministry of Health and Family Welfare at the #CIIDigitalHealthSummit2025 #CII4DigitalHealth #CII4Health #AIinHealth #HealthcareInnovation #PoweringDigitalHealth @CII4Health @MoHFW_INDIA

Use of AI in the regulatory system -there is immense opportunity in various manual reviews, AI can cut time significantly. Still the onus is on the company to do the self regulation. We have issued 4000 manufacturing licenses in India. Meanwhile for import licenses 11,800 with multiple product per licenses. - Dr Rajeev Singh Raghuvanshi, Drugs Controller General of India (DCGI) Central Drugs Standard Control Organisation, at the #CIIDigitalHealthSummit2025 #CII4DigitalHealth #CII4Health #AIinHealth #HealthcareInnovation #PoweringDigitalHealth @CII4Health @MoHFW_INDIA @CDSCO_INDIA_INF

For a country like India, we need to integrate physical and digital healthcare services. This is already happening in areas like payments, R&D, governance and education. Healthcare needs to follow that path too. But healthcare presents unique challenges that we still need to solve. - @satishkannan16, Co-founder and Chief Executive Officer, @MediBuddyapp, at the #CIIDigitalHealthSummit2025 #CII4DigitalHealth #CII4Health #AIinHealth #HealthcareInnovation #PoweringDigitalHealth @CII4Health

The strength of technology lies in ways it can enhance the efficiency, effectiveness and productivity of medical personnel and what they are able to deliver. - S. Krishnan, Secretary, Ministry of Electronics and Information Technology at the 4th #CIIDigitalHealthSummit25 #CII4DigitalHealth #CII4Health #AIinHealth #HealthcareInnovation #PoweringDigitalHealth @GoI_MeitY @SecretaryMEITY @CII4Health

Post COVID the medical systems got upgraded - more technology was applied because of the urgency which was there at that point in time, and the manner in which it enabled us in an emergency situation to upgrade the entire infrastructure, technology ensured we were in a far better position. - S. Krishnan, Secretary, Ministry of Electronics and Information Technology at the 4th #CIIDigitalHealthSummit25 #CII4DigitalHealth #CII4Health #AIinHealth #HealthcareInnovation #PoweringDigitalHealth @GoI_MeitY @SecretaryMEITY @CII4Health

CII, in partnership with Medibuddy, releases the report on ‘Workplace Health Reimagined: Corporate India’s Readiness for Digital Health Leadership’ at the at the 4th #CIIDigitalHealthSummit25 #CII4DigitalHealth #CII4Health #AIinHealth #HealthcareInnovation #PoweringDigitalHealth @MediBuddyapp @CII4Health

Today we are talking about the opportunity that digital has ahead of it, not just in India but for the globe - a USD 40 Bn opportunity that Indian digital health ecosystem can unlock and take forward. This year, at the 4th Digital Health Summit, the conversation is about what we can do not just for Indians but for the world. - Shashank ND, Co-chairman, CII National Committee on Health Technology and Chairman, CII Sub-committee on Digital Health & Co-founder and Chief Executive Officer, @Practo at the #CIIDigitalHealthSummit2025 #CII4DigitalHealth #CII4Health #AIinHealth #HealthcareInnovation #PoweringDigitalHealth @CII4Health @shashanknd